Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.

Saved in:
Bibliographic Details
Title: Systemic high-dose dexamethasone treatment may modulate the efficacy of intratumoral viral oncolytic immunotherapy in glioblastoma models.
Authors: Koch MS; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Zdioruk M; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Nowicki MO; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Griffith AM; Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Aguilar E; Candel Therapeutics, Needham, Massachusetts, USA., Aguilar LK; Candel Therapeutics, Needham, Massachusetts, USA., Guzik BW; Candel Therapeutics, Needham, Massachusetts, USA., Barone F; Candel Therapeutics, Needham, Massachusetts, USA., Tak PP; Candel Therapeutics, Needham, Massachusetts, USA., Tabatabai G; Department of Neurology and Interdisciplinary Neuro-Oncology, University Hospital Tuebingen, Tuebingen, Germany., Lederer JA; Harvard Medical School, Boston, Massachusetts, USA.; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts, USA., Chiocca EA; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA., Lawler S; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA slawler@bwh.harvard.edu.; Harvard Medical School, Boston, Massachusetts, USA.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jan; Vol. 10 (1).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first